More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Cannabis Business Times, Cannabis Aficionado, and Pet Insight Among Recent Media Coverage

Cannabis Business Times, Cannabis Aficionado, and Pet Insight Among Recent Media Coverage

by adminAdrianRamirez | Feb 13, 2019 | HempMeds, Kannaway, Media Coverage

Hemp and CBD dominate the headlines again this week, as hemp legalization, CBD products, and CBD for pets continue to trend as popular topics. Medical Marijuana, Inc. and our portfolio of companies were in the news again this past week, highlighting the booming CBD...
Cannabis Business Times, Cannabis Aficionado, and Pet Insight Among Recent Media Coverage

CANNABIS BUSINESS TIMES, CANNABIS AFICIONADO, UND PET INSIGHT IN DER JÜNGSTEN MEDIENBERICHTERSTATTUNG

by adminAdrianRamirez | Feb 13, 2019 | HempMeds, Kannaway, Media Coverage

HANF UND CBD DOMINIEREN AUCH DIESE WOCHE WIEDER DIE SCHLAGZEILEN, DA DIE LEGALISIERUNG VON HANF, CBD-PRODUKTEN UND CBD FÜR HAUSTIERE WEITERHIN ALS BELIEBTE THEMEN IM TREND LIEGEN. Medical Marijuana, Inc. und unser Unternehmensportfolio waren in der vergangenen Woche...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at Groom Expo West in Pasadena

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at Groom Expo West in Pasadena

by adminAdrianRamirez | Feb 12, 2019 | Press Releases

SAN DIEGO, Feb. 12, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health announced today that it will be the only CBD company exhibiting at the Groom Expo West at the...
Medical Marijuana, Inc. Subsidiary HempMeds® Signs Agreement with National Distributor Mr. Checkout

Medical Marijuana, Inc. Subsidiary HempMeds® Signs Agreement with National Distributor Mr. Checkout

by adminAdrianRamirez | Feb 6, 2019 | HempMeds, Press Releases

SAN DIEGO, Feb. 6, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® has signed an agreement with national distribution leader Mr. Checkout to...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Second Cannabinoid Medicine Course for Doctors in Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Second Cannabinoid Medicine Course for Doctors in Brazil

by adminAdrianRamirez | Feb 5, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, Feb. 5, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil hosted its second Cannabinoid Medicine course on Feb. 1, 2019, at the HempMeds®...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.